A prognostic study to evaluate surgical risks and methods with left cardiac valvular disease using three-dimensional echocardiography.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038679

Enrollment

Unknown

Registered

2020-09-28

Start date

2020-11-02

Completion date

Unknown

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac valvular disease

Interventions

Case series:three-dimensional echocardiogram

Eligibility

Sex/Gender

Male

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Adult patients with single-valve heart disease (stenosis or regurgitation) are admitted to our hospital from 2020 to 2022.

Exclusion criteria

Exclusion criteria: Patients with coronary artery disease or important organ dysfunction or failure(liver, kidney and others); juvenile patients; combined with cardiomyopathy, pericardial disease, central nervous system disease, and malignant tumor.

Design outcomes

Primary

Measure	Time frame
Strain rate;	—

Countries

China

Contacts

Public ContactShengli Yin

The First Affiliated Hospital of Sun Yat-sen University

yinshl@mail.sysu.edu.cn+86 13922273098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026